ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 107 filers reported holding ERASCA INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,000 | +17.4% | 13,549 | +61.0% | 0.00% | – |
Q2 2023 | $23,000 | +91.7% | 8,418 | +108.2% | 0.00% | – |
Q1 2023 | $12,000 | -62.5% | 4,044 | -45.0% | 0.00% | – |
Q4 2022 | $32,000 | +433.3% | 7,349 | +827.9% | 0.00% | – |
Q3 2022 | $6,000 | +200.0% | 792 | +116.4% | 0.00% | – |
Q2 2022 | $2,000 | -99.3% | 366 | -98.9% | 0.00% | – |
Q1 2022 | $279,000 | +316.4% | 32,442 | +653.6% | 0.00% | – |
Q4 2021 | $67,000 | +36.7% | 4,305 | +85.7% | 0.00% | – |
Q3 2021 | $49,000 | – | 2,318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |